Cisplatin-induced apoptosis in human proximal tubular epithelial cells is associated with the activation of the Fas/Fas ligand system

Histochemistry and Cell Biology

Volumn 111, Issue 5, 1999, Pages 359-365

  Razzaque, M S ^a   Koji, T ^a   Kumatori, A ^b   Taguchi, T ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FAS ANTIGEN; FAS LIGAND; PROPIDIUM IODIDE; TRYPAN BLUE;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE EPITHELIUM; PRIORITY JOURNAL; STAINING;

ANTIGENS, CD95; APOPTOSIS; CELL LINE; CELL SURVIVAL; CISPLATIN; EPITHELIAL CELLS; FAS LIGAND PROTEIN; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; KIDNEY TUBULES, PROXIMAL; MEMBRANE GLYCOPROTEINS; MICROSCOPY, FLUORESCENCE;

EID: 0032984565     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004180050368     Document Type: Article

References (24)

1. Aggarwal SK (1993) A histochemical approach to the mechanism of action of cisplatin and its analogues. J Histochem Cytochem 41:1053-1073
2. Choie DD, del Campo AA, Guarino AM (1980) Subcellular localization of cis-dichlorodiammineplatinum(II) in rat kidney and liver. Toxicol Appl Pharmacol 55:245-252
3. Coles HS, Burne JF, Raff MC (1993) Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118:777-784
4. Dixit M, Yang JL, Poirier MC, Price JO, Andrews PA, Arteaga CL (1997) Abrogation of cisplatin-induced programmed cell death in human breast cancer cells by epidermal growth factor antisense RNA. J Natl Cancer Inst 89:365-373
5. Einhorn LH, Donohue J (1977) Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87:293-298
6. Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung JS, Earnshaw WC, Leibson PJ, Kaufmann SH (1997) Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood 90:935-943
7. Evans DL, Dive C (1993) Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes. Cancer Res 53:2133-2139
8. Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM (1997) The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 57:3823-3829
9. Gobe GC, Axelsen RA (1987) Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis. Lab Invest 56:273-281
10. Goldstein RS, Mayor GH (1983) Minireview. The nephrotoxicity of cisplatin. Life Sci 32:685-690
11. Hakuno N, Koji T, Yano T, Kobayashi N, Tsutsumi O, Taketani Y, Nakane PK (1996) Fas/APO-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia. Endocrinology 137:1938-1948
12. Harrison DJ (1988) Cell death in the diseased glomerulus. Histopathology 12:679-683
13. Henkels KM, Turchi JJ (1997) Induction of apoptosis in cisplatin-sensitive and -resistant human ovarian cancer cell lines. Cancer Res 57:4488-4492
14. Iwamoto M, Koji T, Makiyama K, Kobayashi N, Nakane PK (1996) Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol 180:152-159
15. Koji T, Kobayashi N, Nakanishi Y, Yoshii A, Hashimoto S, Shibata Y, Anjiki N, Yamamoto R, Aoki A, Ueda T, Kanazawa S, Nakane PK (1994) Immunohistochemical localization of Fas antigen in paraffin sections with rabbit antibodies against human synthetic Fas peptides. Acta Histochen Cytochem 27:459-463
16. Loehrer PJ Sr, Chen M, Kim K, Aisner SC, Einhorn LH, Livingston R, Johnson D (1997) Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol 15:3093-3099
17. Megyesi J, Safirstein RL, Price PM (1998) Induction of p21 WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 101:777-782
18. Nagata S (1997) Apoptosis by death factor. Cell 88:355-565
19. Nagata S, Suda T (1995) Fas and Fas ligand: Ipr and gld mutations. Immunol Today 16:39-43
20. Nogae S, Miyazaki M, Kobayashi N, Saito T, Abe K, Saito H, Nakane PK, Nakanishi Y, Koji T (1998) Induction of apoptosis in ischemia-reperfusion model of mouse kidney: possible involvement of Fas. J Am Soc Nephrol 9:620-631
21. Shimizu A, Yamanaka N (1993) Apoptosis and cell desquamation in repair process of ischemic tubular necrosis. Virchows Arch 64:171-180
22. Suda T, Takahashi T, Golstein P, Nagata S (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178
23. Truong LD, Petrusevska G, Yang G, Gurpinar T, Shappell S, Lechago J, Rouse D, Suki WN (1996) Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int 50:200-207
24. Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R, Greil R (1997) Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells. Cancer Res 57:3331-3334